Song He waved his hand: "I won't go to dinner, I have to report this good news quickly. Don't have any concerns about foreign companies,

If needed, call me anytime.

"Okay, go and entertain other Xuan guests, I'll go first.

Song He left with a surprise. While sitting in the car, he took out his mobile phone and called the leader of the General Administration.

He didn't expect that this time, there would be such a big surprise.

Xinming Pharmaceutical is in the province he manages, and he has to take this credit firmly in his own hands.

Go back and ask Xinming Pharma if there is anything else that needs help, and he will give his full support.

Maybe Xinming Pharmaceutical can grow into a private pharmaceutical company with a market value of tens of billions, or even hundreds of billions, an absolute rising star!

Fu Xinming took Fu Liang to Liu Chen and Mike Qiao who were leaving: "Where are you two going?

"Didn't I say before the press conference, we're going to have lunch together. At that time, President Liu was still concerned about whether I could eat or not. I will answer you now, I can eat, and

- happy, the riser is very good

Liu Chen's face was blue and he snorted coldly, "Fu Xinming, don't be too complacent!"

Fu Liang looked at Liu Chen's back as he left in a hurry, and reminded loudly, "Mr. Liu, you haven't told me how much you spent on the formula for painkillers.

Liu is at the foot of-

- One followed and left at a faster pace.

When going to the restaurant, Zheng Xianmin obviously brought a car, but he still got into Fu Xinming's car.

In the car, he began to discuss cooperation with Fu Xinming.

, We jointly develop?

"Old classmate, you are hiding a lot. This painkiller,

Fu Xinming said with a smile: "We haven't seen each other for a few months, let's have two more drinks later.

Zheng Xianmin said bluntly: "Our Bingcheng Pharmaceutical Group has many exclusive patents that have not been authorized to the outside world.

"In Japan, our corporate brand is well-known, and patients are more assured of buying.

"Our funds are also very sufficient, and we can inject billions of cash into this project at any time. I only need to account for % of the shares.

'And you need to develop overseas markets for this drug. I can also help. We have marketing channels in many countries.

Fu Xinming shook his head: "Old classmates, in terms of overseas listing and sales ability, in terms of financial strength, are you comparable to Johnson & Johnson?

"And what do you think Johnson & Johnson's offer will be? If they make the same offer as you, they'll have to pay in dollars.

Halfway through he said, the phone suddenly rang.

"Wait a minute, I'll take a call. Hello? Dr. Edward? I'm on my way to the restaurant

PS: Ask for flowers, ask for evaluation, ask for collection! ! !

Chapter [-]: This Painkiller, We Johnson Produced $[-] Billion!

Dr. Edward hung up the phone and decided to have a good talk with Fu Xinming after dinner.

When Fu Xinming was surrounded by other people just now, he made a phone call to contact the headquarters, and even took a photo of the second phase of the clinical report of Supain.

After seeing it from the headquarters, he immediately authorized him to buy this new drug.

If you can't buy it out, you can spend some more money to buy the pharmaceutical company directly.

Johnson & Johnson spends billions of dollars on new drug research and development every year, accounting for almost one-third of its net profit, and it is precisely because of this that they can

[-] Keep Gauri Tears

And in many cases, they do not lose money by acquiring other pharmaceutical companies.

After buying the pharmaceutical company at a high price, take the formula away and launch it under the Johnson & Johnson brand

As for that pharmaceutical company, it can be packaged and sold, so that a sum of money can be recovered.

Even they can change the pharmaceutical company into a company that produces health food. In this regard, Johnson & Johnson is also the world's top

Although Johnson & Johnson is generally more cautious about investing in new drugs developed by other pharmaceutical companies, if they see a drug with excellent market prospects, they will also invest in clinical second

In the first stage of clinical trials, even in the first stage of clinical investment, or even direct acquisition.

Even though some of these investments failed, others were successful and generated huge profits for J&J.

This kind of investment in unmarketed new drugs is somewhat similar to venture capital. Although the risk is high, the earlier you participate, the more profit you will get after success in the future.

At present, the new painkiller of Xinming Pharmaceutical has only undergone the second clinical phase, and they can invest now at a lower cost.

After all, Johnson & Johnson is one of the leaders in the global painkiller market, which generates billions of dollars in sales for Johnson & Johnson every year.

They are absolutely reluctant to give up, but want to continue to expand!

After arriving at the restaurant, many people took their seats. Only Fu Xinming, Zheng Xianmin and several representatives of pharmaceutical companies with a market value of more than [-] billion were on the main table.

Representatives of many pharmaceutical companies with a market value of several billions sat at other tables, accompanied by other shareholders of Xinming Pharmaceutical.

One by one, those shareholders suddenly became the core figures of all the dining tables.

On the side of the media representatives, Fu Xinming's secretary was also there to talk to them about how to report this incident.

Dr. Edward also sat at the main table. He was not used to this way, but he had to do it.

Because he heard Mike Joe say that this is the characteristic of the East. He likes to chat about work at the dinner table, and he chats while drinking.

Although in the United States, some jobs are also chatted in restaurants, but when they chat, they will never drink such strong liquor and use such a big glass

"Everyone, thank you for coming today,

I toast everyone.

Fu Xinming raised his wine glass and drank the two-and-a-half glass of Maotai in one gulp.

Dr. Edward's eyes widened, is this kind of spirit drink like this?

He didn't want to drink, but the representatives of other pharmaceutical companies next to him were staring at him, and he thought it might be rude not to drink.

Just one more drink, he can drink it.

Who knows that after the oriental people drink and raise their glasses, the guests can also propose to raise their glasses and toast the master together.

After three drinks in a row, Edward felt like a fire in his stomach.

He originally wanted to talk about work, but he had to use the bathroom as an excuse to ask the restaurant staff for a bottle of pure water, which he drank.

But seeing other people chatting happily with Fu's father and son, he also heard the word "cooperation" in Chinese, which he didn't know much, which made him

I wanted to leave,

He had to stop and forced himself back to the table.

He suddenly saw Fu Liang sitting on the table next to him. This person seemed to be the person in charge of drug research and development, and he was the son of the chairman of Xinming Pharmaceutical.

Isn't it okay?

Fu Gaoban was at a table next to him, chatting with representatives of some of Xinming Pharmaceutical's partner companies.

He excused himself to drive, but he didn't drink at all, and no one else dared to persuade him.

He was eating vegetables when suddenly a man who smelled of alcohol sat down beside him

"Mr. Xiaofu, let's talk about cooperation, we, Johnson & Johnson, are very sincere, and I have been authorized by the headquarters to represent the company with full authority.

The company will discuss cooperation with you.

Fu Liang threw a silkworm chrysalis into his mouth: "Do you Americans like to talk about work while eating?"

Edward looked at the silkworm barrel in horror and endured the discomfort: "Mr. Xiao Fu, but I heard that the oriental people like to eat and chat, so I do as the locals do.

Fu Diantian nodded: "Okay, you don't think it's rude to eat and chat, then let's chat.

For Xinming Pharmaceutical at this time, the assets are still too small, although in the next three to five years, it will definitely be able to obtain billions of profits.

However, if you cooperate with an industry leader like Johnson & Johnson, you may be able to earn billions of dollars a year. Johnson & Johnson's new drug development and sales capabilities are not vegetarian.

Maybe he can get some discarded prescriptions from Johnson & Johnson, which is what interests Fu Liang the most.

Edward was relieved to hear that Fu Liang had agreed. If he could talk, he would have great confidence to win

And it must be fast. This news will definitely reach the ears of pharmaceutical giants such as Bayer and Pfizer soon. When there is competition, it will be even more difficult to win

"Mr. Xiaofu, I have two plans for cooperation with your company. Each plan will definitely not be a loss for President Xiaofu.

"The first option is that we, Johnson & Johnson, can invest a sum of money in this painkiller project.

"We, Johnson & Johnson, have strong personal connections in the pharmaceutical field of many countries, and we can make this drug available in many countries as soon as possible, and we

A strong team of lawyers can ensure that everyone's interests are not damaged.

"If you only agree, then the drug can be clinically studied in multiple countries at the same time, and by this time next year at the latest, we will be able to conduct clinical research in the whole country.

The ball is listed simultaneously.

"Combined with our Johnson & Johnson sales capabilities, you will be guaranteed a profit of at least $[-] million a year.

"And we can invest $[-] billion right away, coupled with our strong R&D and sales capabilities of Johnson & Johnson, as long as we take [-]% of the shares

Fu Liang shook his head: "In other words, you have invested [-] billion, and you want to share at least [-] million US dollars every year in the future, do you think I will agree?

Edward emphasized: "But without our help, your company's products can only be listed in your country's market next year, with a profit of [-] million US dollars.

Even good.

"And we also have to bear the risk of possible side effects of this drug, especially the long-term side effects, Mr. Xiao Fu may have heard of it, we are on this

suffered a great loss.

Before the long-term use of additives in nursing products, Johnson & Johnson caused some women to suffer from cancer. After being sued, it compensated [-] plaintiffs in total.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like